Table 2.

Clinical monitoring of VHL patients with retinal HBs receiving propranolol in an off-label treatment: previous lesions, dosage, and response to the treatment.

Case	Gender, Age	Lesions Prior to Propranolol Treatment	Propranolol Treatment Initiation (months)	Propranolol Treatment Doses (mg/kg/day)	Response to Propranolol Treatment
1	Female, 32	Bilateral retinal HB	January 2017 (36 months)	Started at 0.66 and increased to 1.5	No lesions detected along the treatment
2	Male, 24	Medulla HB extracted and partial nephrectomy due to ccRCC left renal lesions	May 2018 (22 months)	Started at 0.66 and increased to 1.2	Stable bilateral cystic lesions after starting treatment
3	Male, 28	Left eye retinal HB, multiple tumoral and cystic lesions	August 2016 (47 months)	Started at 0.5 and increased to 1.4	Stable bilateral lesions but one after starting treatment
4	Male, 22	Right eye retinal HB and extracted cerebellum HB	April 2018 (16 months)	1.8	Stable 3 bilateral cystic lesions after starting treatment